Lilly Overtakes Pfizer as Biggest DTC Advertising Spender!
According to cegedim Strategic Data, Lilly overtook Pfizer in total direct-to-consumer (DTC) spending in April, 2012. The chart below shows the top 10 DTC spenders...
Fake vs. Real Pharma Twitter Followers
Piotr Wrzosinski (@pwrzosin), IPM Digital Marketing at Roche and a member of my Pharma Twitter Pioneer Group (see here), recently posted this to Twitter...
How Johnson & Johnson Uses Twitter for Patient Support: A-plus for Effort, D-minus for...
Every day, I get a synopsis of tweets and newsfeeds from selected pharma companies that I am following (see "News Direct from the Pharma...
What’s the Future of DTC Advertising?
Please take a few minutes to tell us your opinion of the future of Direct-to-Consumer (DTC) advertising of prescription medications under a new Democratic Administration. In this survey, please focus on the near future: ie, 2009 and 2010.
New Pharma Business Model: Prizes, Not Patents, for Innovative Drugs
A BMJ articled titled "Pharmaceutical research and development: what do we get for all that money?" was roundly criticized by Rich Meyer of World...
Who’s Your Social Media Daddy? A Panel Discussion
That is one of the questions/topics discussed by a panel of experts I moderated at the PharmaForce conference in Princeton, NJ, on October 30,...
Is Type 2 Diabetes Drug Marketing Responsible for Misdiagnosis of Type 1 Diabetics?
A Wall Street Journal article documents several cases of people being misdiagnosed by general practitioners as having Type 2 diabetes when they actually have...
Pfizer and Janssen Halt Alzheimer Drug Development: Why Not Try Gamification?
"In the wake of another negative trial with the anti-amyloid biologic drug bapineuzumab, Pfizer and Janssen said they were halting development of the product...
Cure by Gamification: Science or Wishful Thinking?
Last week, I wrote about a video game -- Akili, meaning "wisdom" in Swahili -- that the developers plan to submit to the FDA...
Does Generic Competition Stifle Branded Pharma Innovation?
Sure, use of generic drugs saves payers -- U.S. Gov't, insurances companies, and patients -- money. But does generic competition harm the innovation of...
